This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteers or Atopic Disease
and you are
between 18 and 60
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This is a Phase 1b, combined multiple dose subcutaneous (SC) bioavailability (BA) and multiple ascending dose (MAD) study evaluating safety, tolerability and BA of SC XmAb7195 in healthy subjects and in subjects with atopic disease.

Provided treatments

  • Drug: XmAb7195
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02881853. The sponsor of the trial is Xencor, Inc. and it is looking for 57 volunteers for the current phase.
Official trial title:
Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195